Drugs Made In America Acquisition Corp. (DMAA)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$10.45
Day's range
$10.49

Drugs Made In America Acquisition Corp. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
KARPUS MANAGEMENT, INC. 08/14/2026 2.51 M $26.71 M   -0.90% 12.48%
MIZUHO SECURITIES USA LLC 07/28/2026 2.07 M $21.93 M   3.48% 10.30%
POLAR ASSET MANAGEMENT PARTNERS INC. 08/14/2026 1.15 M $12.20 M   -28.38% 5.70%
GLAZER CAPITAL, LLC 08/17/2026 999.90 K $10.65 M   -40.43% 4.98%
WOLVERINE ASSET MANAGEMENT LLC 08/10/2026 832.09 K $8.86 M   -46.44% 4.14%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 08/14/2026 809.05 K $8.62 M   -38.86% 4.03%
FIRST TRUST CAPITAL MANAGEMENT L.P. 08/13/2026 786.46 K $8.38 M   -64.93% 3.91%
HEIGHTS CAPITAL MANAGEMENT, INC 08/14/2026 648.08 K $6.90 M   -0.29% 3.23%
WESTCHESTER CAPITAL MANAGEMENT, LLC 08/14/2026 581.79 K $6.20 M   -65.14% 2.90%
CLEAR STREET GROUP INC. 08/12/2026 382.44 K $1.65 M   8.02% 1.90%
ARISTEIA CAPITAL LLC 08/14/2026 350.00 K $3.73 M   -60.30% 1.74%
SONA ASSET MANAGEMENT (US) LLC 08/14/2026 162.80 K $1.73 M   0.00% 0.81%
RLH CAPITAL LLC 08/10/2026 115.61 K $1.23 M   -63.48% 0.58%
LOGAN STONE CAPITAL, LLC 08/14/2026 109.96 K $1.17 M   100.00% 0.55%
TORONTO DOMINION BANK 08/14/2026 100.00 K $1.07 M   -50.94% 0.50%
METEORA CAPITAL, LLC 08/14/2026 97.84 K $1.04 M   -74.27% 0.49%
QUARRY LP 08/14/2026 65.55 K $698.12 K   -75.41% 0.33%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 62.27 K $663.21 K   0.00% 0.31%
JPMORGAN CHASE & CO 08/12/2026 49.89 K $531.34 K   0.02% 0.25%
DAKOTA WEALTH MANAGEMENT 08/07/2026 36.40 K $387.66 K   0.00% 0.18%
LINEAGE POINT CAPITAL LP 08/14/2026 31.84 K $339.10 K   0.00% 0.16%
HRT FINANCIAL LP 08/14/2026 18.48 K $196.00 K   -32.76% 0.09%
MORGAN STANLEY 08/13/2026 28 $298   -51.72% 0.00%
GOLDMAN SACHS GROUP INC 08/14/2026 0 $0   -100.00% 0.00%
D. E. SHAW & CO., INC. 08/14/2026 0 $0   -100.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 0 $0   -100.00% 0.00%
AQR ARBITRAGE LLC 08/14/2026 0 $0   -100.00% 0.00%
RADCLIFFE CAPITAL MANAGEMENT, L.P. 08/14/2026 0 $0   -100.00% 0.00%
WHITEBOX ADVISORS LLC 08/14/2026 0 $0   -100.00% 0.00%
CONTEXT CAPITAL MANAGEMENT, LLC 07/23/2026 0 $0   -100.00% 0.00%
HUDSON BAY CAPITAL MANAGEMENT LP 08/14/2026 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 09/02/2026 0 $0   -100.00% 0.00%
RIVERNORTH CAPITAL MANAGEMENT, LLC 08/14/2026 0 $0   -100.00% 0.00%
DLD ASSET MANAGEMENT, LP 08/13/2026 0 $0   -100.00% 0.00%
LMR PARTNERS LLP 08/14/2026 0 $0   -100.00% 0.00%
WARBERG ASSET MANAGEMENT LLC 08/11/2026 0 $0   -100.00% 0.00%
GOVERNORS LANE LP 08/14/2026 0 $0   -100.00% 0.00%
PERISCOPE CAPITAL INC. 08/11/2026 0 $0   -100.00% 0.00%
SHAOLIN CAPITAL MANAGEMENT LLC 08/14/2026 0 $0   -100.00% 0.00%
L1 GLOBAL MANAGER PTY LTD 08/13/2026 0 $0   -100.00% 0.00%

Drugs Made In America Acquisition Corp. institutional Ownership - FAQ's

During the previous two years, 44 institutional investors and hedge funds held shares of Drugs Made In America Acquisition Corp.. The most heavily invested institutionals were:

Karpus Management, Inc.: 2.51 M

MIZUHO SECURITIES USA LLC: 2.07 M

Polar Asset Management Partners Inc.: 1.15 M

GLAZER CAPITAL, LLC: 999,899

WOLVERINE ASSET MANAGEMENT LLC: 832,093

HIGHBRIDGE CAPITAL MANAGEMENT LLC: 809,054

59.54% of Drugs Made In America Acquisition Corp. stock is owned by institutional investors.

Institutional investors have bought a total of 13.12 M shares in the last 24 months. This purchase volume represents approximately $137.36 M in transactions.